Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/10/2020
SIETES contiene 93137 citas

 
 
 1 a 20 de 183 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Sevilla-Sánchez D, Molist-Brunet N, Amblàs-Novellas J, Roura-Poch P, Espaulella-Panicot J, Codina-Jané C. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission. Eur J Clin Pharmacol 2017;73:79-89. [Ref.ID 101938]
2. Cita con resumen
Agar MR, Lawlor PG, Quinn S, Draper B, Caplan GA, Rowett D, Sanderson C, Hardy J, Le B, Eckermann S, McCaffrey N, Devilee L, Fazekas B, Hill M, Currow DC. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med 2017;177:34-42. [Ref.ID 101343]
4. Cita con resumen
Anónimo. FDA approves first dronabinol solution for oral use. U.S. Food and Drug Administration 2016:2. [Ref.ID 100472]
5. Cita con resumen
Mitchell SL. Advanced dementia. N Engl J Med 2015;372:2533-40. [Ref.ID 99313]
6. Cita con resumen
Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK. Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncology 2015;1:778-84. [Ref.ID 99274]
7. Cita con resumen
Zimmermann C, Swami N, Krzyanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014;383:1721-30. [Ref.ID 97608]
8. Cita con resumen
Frechen S, Zoeller A, Ruberg K, Voltz R, Gaerter J. Drug interactions in dying patients: a retrospective analysis of hospice impatients in Germany. Drug Saf 2012;35:745-58. [Ref.ID 93642]
10.Tiene citas relacionadas Cita con resumen
Zhang B, Nilsson ME, Prigerson HG. Factors important to patients' quality of life at the end of life. Arch Intern Med 2012;172:1133-42. [Ref.ID 93586]
11. Cita con resumen
Andrews PJD, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA, and the SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial) Trials Group. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011;342:695. [Ref.ID 90344]
12. Cita con resumen
Anónimo. Savoir ne pas traiter par chimiothérapie anticancéreuse en fin de vie. Prescrire 2011;31:24-5. [Ref.ID 89994]
13. Cita con resumen
Hoffmann DE, Weber E. Medical marijuana and the law. N Engl J Med 2010;362:1453-7. [Ref.ID 88297]
14. Cita con resumen
Vissers KCP, Hassellar JGJ. Palliative sedation. Need for consensus guidelines and standards. Arch Intern Med 2010;170:494-5. [Ref.ID 88067]
15.
Chambaere K, Bilsen J, Cohen J, Rietjens JA, Onwuteaka-Philipsen BD, Mortier F, Deliens L. Continuous deep sedation until death in Belgium: a nationwide survey. Arch Intern Med 2010;170:490-3. [Ref.ID 88066]
16. Cita con resumen
Bakitas M, Lyons KD, Hegel MT, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA. Effects of a pallative care intervention on clinical outcomes in patients with advanced cancer. The Project ENABLE II randomized controlled trial. JAMA 2009;302:741-9. [Ref.ID 86568]
18.Enlace a cita original
Borgsteede SD, Deliens L, Zuurmond WWA, Schellevis FG, Willems DL, van der Wal G, van Eijk JTM. Prescribing of pain medication in palliative care. A survey in general practice. Pharmacoepidemiol Drug Saf 2009;18:16-23. [Ref.ID 85177]
19. Cita con resumen
20.
Falit BP, Gross CP. Access to experimental drugs for terminally ill patients. JAMA 2008;300:2793-5. [Ref.ID 84773]
Seleccionar todas
 
 1 a 20 de 183 siguiente >>